MADRIGAL PHARMACEUTICALS, INC. (MDGL) Analyst Insights
| Ratings | Buy | Hold | Sell | Other ratings | Last Close | Average Target | Upside | High Target | Low Target |
|---|
| (m) | (m) | (m) | (m) | (m) | $399.83 | (m) | (m) | (m) | (m) |
| Date | Stock | Analyst | Firm | Price When Rated | Price Target | Upside / Downside | Rating | Performance |
|---|
| 2026-07-31 | MDGL
MADRIGAL PHARMACEUTICALS, INC. | Eliana Merle, CFA | Barclays | $493.11 | $962.00 | +95.09% | Overweight | |
|---|
| 2026-01-27 | MDGL
MADRIGAL PHARMACEUTICALS, INC. | Eliana Merle, CFA | Barclays | $480.45 | $964.00 | +100.65% | Overweight | |
|---|